Búsqueda | Portal de Búsqueda de la BVS España

1.

Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.

Gillmore, Julian D; Judge, Daniel P; Cappelli, Francesco; Fontana, Marianna; Garcia-Pavia, Pablo; Gibbs, Simon; Grogan, Martha; Hanna, Mazen; Hoffman, James; Masri, Ahmad; Maurer, Mathew S; Nativi-Nicolau, Jose; Obici, Laura; Poulsen, Steen Hvitfeldt; Rockhold, Frank; Shah, Keyur B; Soman, Prem; Garg, Jyotsna; Chiswell, Karen; Xu, Haolin; Cao, Xiaofan; Lystig, Ted; Sinha, Uma; Fox, Jonathan C.

N Engl J Med; 390(2): 132-142, 2024 Jan 11.

Artículo en Inglés | MEDLINE | ID: mdl-38197816

2.

Acoramidis in Transthyretin Amyloid Cardiomyopathy. Reply.

Gillmore, Julian D; Lystig, Ted; Fox, Jonathan C.

N Engl J Med; 390(14): 1346-1347, 2024 Apr 11.

Artículo en Inglés | MEDLINE | ID: mdl-38598813

3.

Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1.

Gafni, Rachel I; Hartley, Iris R; Roszko, Kelly L; Nemeth, Edward F; Pozo, Karen A; Lombardi, Ed; Sridhar, Ananth V; Roberts, Mary S; Fox, Jonathan C; Collins, Michael T.

N Engl J Med; 389(13): 1245-1247, 2023 Sep 28.

Artículo en Inglés | MEDLINE | ID: mdl-37754292

4.

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).

Ho, Carolyn Y; Day, Sharlene M; Ashley, Euan A; Michels, Michelle; Pereira, Alexandre C; Jacoby, Daniel; Cirino, Allison L; Fox, Jonathan C; Lakdawala, Neal K; Ware, James S; Caleshu, Colleen A; Helms, Adam S; Colan, Steven D; Girolami, Francesca; Cecchi, Franco; Seidman, Christine E; Sajeev, Gautam; Signorovitch, James; Green, Eric M; Olivotto, Iacopo.

Circulation; 138(14): 1387-1398, 2018 10 02.

Artículo en Inglés | MEDLINE | ID: mdl-30297972

5.

Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.

Povsic, Thomas J; Scott, Rob; Mahaffey, Kenneth W; Blaustein, Robert; Edelberg, Jay M; Lefkowitz, Martin P; Solomon, Scott D; Fox, Jonathan C; Healy, Kevin E; Khakoo, Aarif Y; Losordo, Douglas W; Malik, Fady I; Monia, Brett P; Montgomery, Rusty L; Riesmeyer, Jeffrey; Schwartz, Gregory G; Zelenkofske, Steven L; Wu, Joseph C; Wasserman, Scott M; Roe, Matthew T.

Cardiovasc Drugs Ther; 31(4): 445-458, 2017 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-28735360

6.

SHaRe: advancing the goal of effective treatment for cardiomyopathy.

Fox, Jonathan C.

Eur Heart J; 36(19): 1142-3, 2015 May 14.

Artículo en Inglés | MEDLINE | ID: mdl-26171479

7.

AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury.

Stone, Joshua D; Narine, Avinash; Shaver, Patti R; Fox, Jonathan C; Vuncannon, Jackson R; Tulis, David A.

Am J Physiol Heart Circ Physiol; 304(3): H369-81, 2013 Feb 01.

Artículo en Inglés | MEDLINE | ID: mdl-23203966

8.

Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.

Roszko, Kelly L; Stapleton Smith, Lyndsay M; Sridhar, Ananth V; Roberts, Mary Scott; Hartley, Iris R; Gafni, Rachel I; Collins, Michael T; Fox, Jonathan C; Nemeth, Edward F.

J Bone Miner Res; 37(10): 1926-1935, 2022 10.

Artículo en Inglés | MEDLINE | ID: mdl-35879818

9.

The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways.

Joshi, Chintamani N; Martin, Danielle N; Fox, Jonathan C; Mendelev, Natalia N; Brown, Trisha A; Tulis, David A.

J Pharmacol Exp Ther; 339(2): 394-402, 2011 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-21825001

10.

First-in-Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers.

Fox, Jonathan C; Hellawell, Jennifer L; Rao, Satish; O'Reilly, Terry; Lumpkin, Rick; Jernelius, Jesper; Gretler, Daniel; Sinha, Uma.

Clin Pharmacol Drug Dev; 9(1): 115-129, 2020 01.

Artículo en Inglés | MEDLINE | ID: mdl-31172685

11.

Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.

Judge, Daniel P; Heitner, Stephen B; Falk, Rodney H; Maurer, Mathew S; Shah, Sanjiv J; Witteles, Ronald M; Grogan, Martha; Selby, Van N; Jacoby, Daniel; Hanna, Mazen; Nativi-Nicolau, Jose; Patel, Jignesh; Rao, Satish; Sinha, Uma; Turtle, Cameron W; Fox, Jonathan C.

J Am Coll Cardiol; 74(3): 285-295, 2019 07 23.

Artículo en Inglés | MEDLINE | ID: mdl-30885685

12.

Autocrine signaling through Ras regulates cell survival activity in human glioma cells: potential cross-talk between Ras and the phosphatidylinositol 3-kinase-Akt pathway.

Sakata, Kiyohiko; Kato, Seiya; Fox, Jonathan C; Shigemori, Minoru; Morimatsu, Minoru.

J Neuropathol Exp Neurol; 61(11): 975-83, 2002 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-12430714

13.

Inhibition of autocrine fibroblast growth factor signaling by the adenovirus-mediated expression of an antisense transgene or a dominant negative receptor in human glioma cells in vitro.

Aoki, Takachika; Kato, Seiya; Fox, Jonathan C; Okamoto, Kenichi; Sakata, Kiyohito; Morimatsu, Minoru; Shigemori, Minoru.

Int J Oncol; 21(3): 629-36, 2002 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-12168110

14.

Investigating cardiovascular risk reduction--the Rosuvastatin GALAXY Programme.

Schuster, Herbert; Fox, Jonathan C.

Expert Opin Pharmacother; 5(5): 1187-200, 2004 May.

Artículo en Inglés | MEDLINE | ID: mdl-15155117

15.

The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.

Fox, Jonathan C; Leight, Kellie; Sutradhar, Santosh C; Demopoulos, Laura A; Gleim, Gilbert W; Lewin, Andrew J; Bakris, George L.

J Clin Hypertens (Greenwich); 6(8): 437-42; quiz 443-4, 2004 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-15308882

16.

Restoration of cytoskeleton homeostasis after gigaxonin gene transfer for giant axonal neuropathy.

Mussche, Silke; Devreese, Bart; Nagabhushan Kalburgi, Sahana; Bachaboina, Lavanya; Fox, Jonathan C; Shih, Hung-Jui; Van Coster, Rudy; Samulski, R Jude; Gray, Steven J.

Hum Gene Ther; 24(2): 209-19, 2013 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-23316953

17.

Rosuvastatin-warfarin drug interaction.

Olsson, Gunnar O; Fox, Jonathan C.

Lancet; 363(9412): 897, 2004 Mar 13.

Artículo en Inglés | MEDLINE | ID: mdl-15031044

18.

Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.

Saito, Yasushi; Yamada, Nobuhiro; Shirai, Kohji; Sasaki, Jun; Ebihara, Yoshinori; Yanase, Toshihiko; Fox, Jonathan C.

Atherosclerosis; 194(2): 505-11, 2007 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-17223112

19.

The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy.

McAfee, Andrew T; Ming, Eileen E; Seeger, John D; Quinn, Sherry G; Ng, Eva W; Danielson, Jared D; Cutone, Jennifer A; Fox, Jonathan C; Walker, Alexander M.

Pharmacoepidemiol Drug Saf; 15(7): 444-53, 2006 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-16761308

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: